A single inhaled dose of INS316 (uridine 5¢-triphosphate, UTP) enhances sputum quality for the diagnosis of lung cancer
D. M. Jablons, D. Everett, G. David, R. Y. Michels, M. G. Klein, P. Edgar, F. L. Johnson (San Francisco, Grand Junction, Durham, United States Of America)
Source: Annual Congress 2001 - Lung cancer diagnosis
Session: Lung cancer diagnosis
Session type: Thematic Poster Session
Number: 508
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. M. Jablons, D. Everett, G. David, R. Y. Michels, M. G. Klein, P. Edgar, F. L. Johnson (San Francisco, Grand Junction, Durham, United States Of America). A single inhaled dose of INS316 (uridine 5¢-triphosphate, UTP) enhances sputum quality for the diagnosis of lung cancer. Eur Respir J 2001; 16: Suppl. 31, 508
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients Source: Annual Congress 2009 - New drugs for airways disease Year: 2009
Protective effect of budesonide/formoterol in a model of repeated exposure to inhaled adenosine 5‘-monophosphate (AMP) in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 353s Year: 2007
Roflumilast, an oral, once-daily PDE4 inhibitor, improves lung function and reduces exacerbation rates in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 21s Year: 2004
Low doses of inhaled fluticasone propionate induce sputum eosinophil apoptosis and inhibit IL-5 release in naive symptomatic asthmatics (FLIC19) Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Dose response to budesonide using adenosine monophosphate (AMP) bronchial challenge: assessment of two dry powder inhalers Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002
Adenosine 5’ – triphosphate (ATP) and adenosine 5' – monophosphate (AMP) challenge testing in current smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003
Effect of adenosine 5´-triphosphate (ATP) challenge vs. adenosine 5´-monophosphate (AMP) on the threshold of capsaicin-induced cough in healthy non-smokers, current smokers and patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 708s Year: 2004
Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine Source: Eur Respir J 2002; 19: 611-616 Year: 2002
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Roflumilast, a PDE4 inhibitor, improves lung function in patients with COPD treated with tiotropium Source: Annual Congress 2009 - Treatment of COPD Year: 2009
Effect of piclamilast, a selective phosphodiesterase (IV)-inhibitor, theophylline and prednisolone, on sputum cell and blood neutrophil oxidative burst from mild asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003
Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006
Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Effect of budesonide on AMP and methacholine airway responsiveness and sputum cellularity: a time-course study Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Increase of skin reactivity to histamine after chemotherapy in patients with lung cancer Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007